Appendix 2A — Application for Quotation of +Securities

Dec 1, 2021
Posted in: News, Investor updates

Home » Appendix 2A — Application for Quotation of +Securities

Appendix 2A — Application for Quotation of +Securities

Dec 1, 2021
Posted in: News, Investor updates

The following Appendix 2A was announced via ASX on 1 Dec 2021.

Please click to review full announcement.

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

August 21, 2025

Earlier this month, our own Bob Proulx, Executive Chairman of Imagion Biosystems, had the opportunity to join Stuart Roberts on Pitt Street Research’s podcast Stocks

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

August 13, 2025

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging

IBX Secures Firm Commitments for A$3.5M Capital Raising

August 4, 2025

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer cells utilising its proprietary MagSense®

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appendix 2A — Application for Quotation of +Securities

Appendix 2A — Application for Quotation of +Securities

Related Articles

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

IBX Secures Firm Commitments for A$3.5M Capital Raising

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list